It was a shocking Friday. Both the new releases tanked perhaps
because of the lack of aggressive promotion. Sudhir Mishra’s
Khoya Khoya Chand, masterful in its sets and ambience, could not
grab the audience’s interest.Sanjay Gupta’s Dus Kahaniyaan was
the other loser. Oddly enough, a couple of its screenings in Mumbai
had faulty screenings.
Frank Micelotta: FOXCliff Wagner and the Old No. 7, fresh off the
farm. The Next Great American Band "Two bands leave; eight bands
perform" Nov. 9, 2007 Here's a sure-fire way to kill an already
ailing show: Kill off...
Roche announced the submission of a biologics license application
(BLA) to the U.S. Food and Drug Administration (FDA) seeking
approval for ACTEMRATM (tocilizumab) to reduce the signs and
symptoms in adults with moderate to severe rheumatoid arthritis
(RA). "The filing for ACTEMRA in the U.S. [click link for full
article]
Cora Knapp bent her blonde head over the jumble of red, yellow and
orange feathers on the math center table. A feather with one dot
went to the numeral one on her turkey. Two dots went with the
numeral two, and so on.
1 Biohazard
Waco Jesus
It was a shocking Friday. Both the new releases tanked perhaps because of the lack of aggressive promotion. Sudhir Mishra’s Khoya Khoya Chand, masterful in its sets and ambience, could not grab the audience’s interest.Sanjay Gupta’s Dus Kahaniyaan was the other loser. Oddly enough, a couple of its screenings in Mumbai had faulty screenings.
2 Tom Petty
Waco Jesus
Dr. Gertes performed an illusion where he magically vanish a silk on his hand.
3 Galaxie 500
Waco Jesus
Fifteen key economists, policymakers and strategists weigh in on a week of volatility and economic turmoil.
4 Salakavala
Waco Jesus
Frank Micelotta: FOXCliff Wagner and the Old No. 7, fresh off the farm. The Next Great American Band "Two bands leave; eight bands perform" Nov. 9, 2007 Here's a sure-fire way to kill an already ailing show: Kill off...
5 Spring Heel Jack
Waco Jesus
Roche announced the submission of a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for ACTEMRATM (tocilizumab) to reduce the signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA). "The filing for ACTEMRA in the U.S. [click link for full article]
6 Cliff Eidelman
Waco Jesus
Cora Knapp bent her blonde head over the jumble of red, yellow and orange feathers on the math center table. A feather with one dot went to the numeral one on her turkey. Two dots went with the numeral two, and so on.